Posaconazole has better therapeutic efficacy in comparison with itraconazole and voriconazole in ABPA amongst Cystic Fibrosis patients

Posaconazole has better therapeutic efficacy in comparison with itraconazole and voriconazole in ABPA amongst Cystic Fibrosis patientsTue, 03/12/2019 - 11:22News blog

Source: The Aspergillus Website - updates - March 12, 2019 Category: Respiratory Medicine Authors: helenfindon Source Type: news